323 reports of this reaction
3.2% of all NALOXONE HYDROCHLORIDE reports
#3 most reported adverse reaction
PAIN is the #3 most commonly reported adverse reaction for NALOXONE HYDROCHLORIDE, manufactured by Emergent Devices Inc.. There are 323 FDA adverse event reports linking NALOXONE HYDROCHLORIDE to PAIN. This represents approximately 3.2% of all 10,081 adverse event reports for this drug.
Patients taking NALOXONE HYDROCHLORIDE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among NALOXONE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for NALOXONE HYDROCHLORIDE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 323 FDA reports for NALOXONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.2% of all adverse event reports for NALOXONE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience pain while taking NALOXONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.